Immune to Cancer: The CRI Blog
-
Cell Therapy Development Lagged in 2020 But Is Gaining Ground Again, New CRI Report Shows
Cell therapy development lagged in 2020, but is gaining ground again, a new CRI report shows.
-
COVID-19’s Impact on Oncology Clinical Trials: A One-Year Follow-Up Analysis
A new CRI report highlights the impact of the COVID-19 pandemic on cancer clinical trials compared to…
-
Impacto de la pandemia de COVID-19 en los ensayos clínicos oncológicos: análisis de seguimiento a un año
Un nuevo informe del CRI destaca la repercusión de la pandemia de COVID-19 en los ensayos clínicos…
-
12 Challenges for 2021: Fundraising Ideas for Every Month of the Year
Commit to change in 2021 and advance cancer immunotherapy research. Get fundraising ideas for every month of…
-
Skin Cancer Awareness Month: 2021 Immunotherapy Research Updates
This May for Skin Cancer Awareness Month, we look at new research, new treatments, and how we’re…
-
Brain Tumor Awareness Month: 2021 Immunotherapy Research Updates
This May for Brain Tumor Awareness Month, we look at new research, new treatments, and how we’re…
-
Melanoma Monday: 2021 Immunotherapy Research Updates
Today for Melanoma Monday, we look at new research, new treatments, and how we’re working toward a…
-
Bladder Cancer Awareness Month: 2021 Immunotherapy Research Updates
This May for Bladder Cancer Awareness Month, we look at new research, new treatments, and how we’re…
-
Richard Catlett’s Immunotherapy Story
Kidney Cancer | Diagnosed 2007 When I went in to get my results from the study doctor, he…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.